Chris SchottPartner at Latham & WatkinsSpeaker
Profile
Chris Schott primarily advises on price reporting and other compliance obligations related to the Medicaid, Medicare, and 340B drug pricing programs, with a focus on market access. He combines extensive regulatory insight with deep industry knowledge to support pharmaceutical clients at all stages of the product life cycle. Market entrants and investors also seek Chris’s advice when evaluating potential opportunities and strategies.
Agenda Sessions
Fireside Chat with External Counsel Roundtable Part I: Enforcement Trends and Implementation Realities - LIVESTREAM
, 11:10amView Session
